Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

LaserSight

This article was originally published in The Gray Sheet

Executive Summary

Refractive laser firm raises $16 mil. via investments of $8 mil. each by Dawson Samberg Capital Management Funds and TLC The Laser Center, Inc. -both consisting of 2 mil. shares of preferred stock at $4 each. The firm received an additional $4.3 mil. on June 5 in connection with the sale of Vision Twenty-One stock received last December in connection with that firm's acquisition of two of LaserSight's health care subsidiaries ("The Gray Sheet" Jan. 5, In Brief). Proceeds will be used for expansion of the firm's international presence and for U.S. marketing activities, as well as debt repayment and repurchase of all Series B preferred stock. LaserSight and TLC are collaborating to develop a mobile excimer laser business...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT010266

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel